Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ:VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced
Former Treasury Secretary Larry Summers said Fitch's decision to downgrade the U.S. at a time the economy is looking stronger than expected is "bizarre and inept."